Indian Manufactured Typhoid Conjugate Vaccine (TCV) Pre Qualified By WHO

An Indian based company's Typhoid Conjugate Vaccine (TCV) against typhoid fever has received pre-qualification from the World Health Organisation (WHO). The WHO pre-qualification enables the procurement and supplies of this life-saving vaccine to Unicef, the Pan-American Health Organization (PAHO) and GAVI (a vaccine alliance) supported countries. This TCV is the first typhoid vaccine, clinically proven to be administered to children from 6 months of age to adults and confers long-term protection against typhoid fever, said the Chairman and Managing Director of the vaccine company.

International Health Metrics and Evaluation (IHME) estimates that in 2016, there were approximately 12 million cases of typhoid fever resulting in around 130,000 deaths. Typhoid fever is caused by the bacterium Salmonella Typhi (S. Typhi), which infects humans due to contaminated food and beverages from…